Vestis (VSTS) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
12 May, 2026Executive summary
Revenue for Q2 2026 was $659.4 million, down 0.9% year-over-year, with volume declining 1.2% but offset by improved pricing and product mix.
Adjusted EBITDA rose 19.1% to $74.5 million (11.3% margin), driven by operational improvements and cost reductions.
Net income turned positive at $2.6 million versus a net loss of $27.8 million in the prior year.
Transformation initiatives delivered $15 million in realized cost savings year-to-date, with annualized savings expected to reach at least $75 million by year-end.
Operational excellence initiatives improved plant productivity by 11% and on-time deliveries by 270 bps.
Financial highlights
Adjusted EBITDA margin improved to 11.3% from 7.2% prior year.
Free Cash Flow for Q2 was $45.6 million; Adjusted Free Cash Flow was $56.6 million, up $63.5 million year-over-year.
SG&A declined $13.5 million or 12% year-over-year after adjusting for prior-year non-recurring items.
Cash flow from operations for six months was $95.9 million, up from $10.4 million year-over-year.
Debt repayment of $34 million during the quarter; available liquidity at quarter-end was $344.5 million, including $50.3 million in cash.
Outlook and guidance
FY 2026 Adjusted EBITDA guidance raised to $295–$325 million; Free Cash Flow guidance raised to $120–$150 million.
Revenue for FY 2026 expected to be flat to down 2% versus normalized FY 2025 revenue.
Sequential Adjusted EBITDA growth of ~5% expected in Q3 and 5–10% in Q4 2026.
Transformation plan expected to be substantially complete by end of fiscal 2027.
Free Cash Flow outlook reflects $60–$70 million in annual capital expenditures and $30–$35 million in transformation expenses.
Latest events from Vestis
- Q1 2026 revenue fell 3% to $663.4M, with a net loss and progress on a $75M transformation plan.VSTS
Q1 202617 Apr 2026 - Q3 revenue fell 1.6% to $698M; leverage improved to 3.33x after $250M A/R facility.VSTS
Q3 20242 Feb 2026 - FY24 delivered steady results and deleveraging; FY25 targets margin expansion and growth.VSTS
Q4 202412 Jan 2026 - Q1 2025 delivered stable revenue, improved retention, and reaffirmed FY25 growth guidance.VSTS
Q1 20259 Jan 2026 - Transformation plan launched, strong governance, and no 2025 executive bonuses paid.VSTS
Proxy Filing8 Jan 2026 - Definitive Additional Materials filed under SEC Schedule 14A; no fee required.VSTS
Proxy Filing8 Jan 2026 - Transformation plan targets $75M cost savings by 2026; Q4 normalized revenue down 3.5% YoY.VSTS
Q4 20252 Dec 2025 - Shareholders will vote on directors, executive pay, and auditor, as the company advances ESG and governance.VSTS
Proxy Filing2 Dec 2025 - Additional proxy materials update shareholders ahead of the meeting, with no capital changes.VSTS
Proxy Filing2 Dec 2025